Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency
International Journal of Molecular Sciences · 06.03.2023 · 24 (5) · 5023
DOI: 10.3390/ijms24055023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2023. Verfasst von Rosa Cifuentes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pas…. Hauptthemen laut MEDLINE: Thrombophilia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación España, Centre for Biomedical Network Research on Rare Diseases.
Abstract (Originalsprache)
Multiplex ligation-dependent probe amplification (MLPA) identifies genetic structural variants in SERPINC1 in 5% of cases with antithrombin deficiency (ATD), the most severe congenital thrombophilia. Our aim was to unravel the utility and limitations of MLPA in a large cohort of unrelated patients with ATD (N = 341). MLPA identified 22 structural variants (SVs) causing ATD (6.5%). MLPA did not detect SVs affecting introns (four cases), and the diagnosis was inaccurate in two cases according to long-range PCR or nanopore sequencing. MLPA was used to detect possible hidden SVs in 61 cases with type I deficiency with single nucleotide variations (SNVs) or small insertion/deletion (INDEL). One case had a false deletion of exon 7, as the 29-bp deletion affected an MLPA probe. We evaluated 32 variants affecting MLPA probes: 27 SNVs and 5 small INDELs. In three cases, MLPA gave false-positive results, all diagnosed as deletions of the affected exon: a small INDEL complex, and two SNVs affecting MLPA probes. Our study confirms the utility of MLPA to detect SVs in ATD, but also shows some limitations in detecting intronic SVs. MLPA renders imprecise and false-positive results for genetic defects which affect MLPA probes. Our results encourage the validation of MLPA results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER, 30008 Murcia, Spain.
ORCID-Profile: María Eugenia de la Morena-Barrio, Carlos Bravo-Pérez, Pedro Garrido-Rodríguez, Vicente Vicente, María Luisa Lozano
Förderung
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación España
- Centre for Biomedical Network Research on Rare Diseases
- Instituto de Salud Carlos III, Cofinanciado a la Unión Europea and Next Generation UE
- Ministerio de Ciencia e Innovación
- Juan Rodés fellowship
Zitieren
APA
Cifuentes, R., Padilla, J., de la Morena-Barrio, M. E., de la Morena-Barrio, B., Bravo-Pérez, C., Garrido-Rodríguez, P., Llamas, M., Miñano, A., Vicente, V., Lozano, M. L., & Corral, J. (2023). Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency. International Journal of Molecular Sciences, 24(5), 5023. https://doi.org/10.3390/ijms24055023
Vancouver
Cifuentes R, Padilla J, de la Morena-Barrio ME, de la Morena-Barrio B, Bravo-Pérez C, Garrido-Rodríguez P, et al. Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency. International Journal of Molecular Sciences. 2023;24(5):5023. doi:10.3390/ijms24055023
BibTeX
@article{Cifuentes2023,
author = {Cifuentes, Rosa and Padilla, José and de la Morena-Barrio, María Eugenia and de la Morena-Barrio, Belén and Bravo-Pérez, Carlos and Garrido-Rodríguez, Pedro and Llamas, María and Miñano, Antonia and Vicente, Vicente and Lozano, María Luisa and Corral, Javier},
title = {Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {5023},
doi = {10.3390/ijms24055023}
}
EUVIMED